Antigen Design Articles & Analysis: This-Year
2 articles found
However, with advancements in biotechnology and biochemistry, the design of antibody-based therapies has undergone a paradigm shift. Techniques such as recombinant DNA technology and hybridoma technology have allowed scientists to create monoclonal antibodies, which are identical copies of a specific antibody that targets a particular antigen. Innovations in ...
Alfa Cytology's immune checkpoint inhibitor services are specifically designed to address these challenges by offering customized, high-quality solutions that are tailored to the unique immunological characteristics of different cancers. Alfa Cytology’s expertise in immune checkpoint inhibitor development services includes small molecule inhibitors, antibodies, and vaccines. ...